CAS 31384-90-4
:hippuryl-gly-gly
Description:
Hippuryl-gly-gly, also known as hippurylglycylglycine, is a dipeptide derivative that consists of the amino acids glycine and hippuric acid. It is characterized by its structure, which includes a glycine moiety linked to a hippuric acid backbone. This compound is typically used in biochemical research and studies related to peptide synthesis and metabolism. Its properties include being soluble in water, which facilitates its use in various biological assays. Hippuryl-gly-gly may exhibit biological activity, potentially influencing metabolic pathways or serving as a substrate for enzymatic reactions. The compound's CAS number, 31384-90-4, is a unique identifier that allows for easy reference in chemical databases. As with many peptides, its stability and reactivity can be influenced by factors such as pH and temperature, making it important to consider these conditions in experimental settings. Overall, hippuryl-gly-gly serves as a valuable tool in the study of peptide interactions and biological processes.
Formula:C13H15N3O5
InChI:InChI=1/C13H15N3O5/c17-10(15-8-12(19)20)6-14-11(18)7-16-13(21)9-4-2-1-3-5-9/h1-5H,6-8H2,(H,14,18)(H,15,17)(H,16,21)(H,19,20)
SMILES:c1ccc(cc1)C(=NCC(=NCC(=NCC(=O)O)O)O)O
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Bz-Gly-Gly-Gly [Hippuryl-Glycyl-Glycine]
CAS:<p>Bz-Gly-Gly-Gly is a prodrug that is metabolized by enzymatic hydrolysis to its active form, hippurylglycylglycine. The prodrug has been shown to have minimal toxicity in mice and humans, and it binds to the target enzyme of infectious diseases (e.g., HIV) with high affinity. Bz-Gly-Gly-Gly has been shown to be effective in vitro against human immunodeficiency virus type 1 (HIV1) and mouse tumor models, as well as in vivo against mouse leukemia cells. The drug has also been shown to be safe at physiological levels in mice.</p>Formula:C13H15N3O5Purity:Min. 95%Molecular weight:293.28 g/molHippuryl-Gly-Gly-OH
CAS:<p>Hippuryl-Gly-Gly-OH is a small molecule that inhibits the growth of bacteria. It is an inhibitor of epidermal growth factor (EGF) that binds to EGF and blocks its ability to interact with cells. Hippuryl-Gly-Gly-OH also has anti-inflammatory properties and has been shown to be effective against inflammatory bowel disease in vitro. This drug also has been shown to inhibit the enzyme activities associated with inflammatory bowel disease, such as COX2 and iNOS, in human serum, as well as inhibiting the production of proinflammatory cytokines from human peripheral blood mononuclear cells.</p>Formula:C13H15N3O5Purity:Min. 95%Molecular weight:293.28 g/mol

